Wang, J., Ling, S., Ni, J., & Wan, Y. (2022). Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma. BMC.
Lua i Stíl Chicago (17ú heag.)Wang, Jingrui, Sunbin Ling, Jie Ni, agus Yafeng Wan. Novel γδ T Cell-based Prognostic Signature to Estimate Risk and Aid Therapy in Hepatocellular Carcinoma. BMC, 2022.
Lua MLA (9ú heag.)Wang, Jingrui, et al. Novel γδ T Cell-based Prognostic Signature to Estimate Risk and Aid Therapy in Hepatocellular Carcinoma. BMC, 2022.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.